MARKET

STAA

STAA

STAAR Surgical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

48.25
-3.17
-6.16%
After Hours: 48.25 0 0.00% 16:41 08/11 EDT
OPEN
46.84
PREV CLOSE
51.42
HIGH
50.21
LOW
46.40
VOLUME
2.67M
TURNOVER
--
52 WEEK HIGH
62.51
52 WEEK LOW
23.20
MARKET CAP
2.21B
P/E (TTM)
305.77
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average STAA stock price target is 64.60 with a high estimate of 70.00 and a low estimate of 58.00.

EPS

STAA News

More
Staar Surgical stock price target raised to $66 from $55 at Benchmark
marketwatch.com · 5d ago
Staar Surgical (STAA) Misses Q2 Earnings and Revenue Estimates
Staar Surgical (STAA) delivered earnings and revenue surprises of -25.00% and -6.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 5d ago
STAAR Surgical Reports Second Quarter 2020 Results
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the second quarter ended July 3, 2020.
Business Wire · 6d ago
Analysts Estimate Staar Surgical (STAA) to Report a Decline in Earnings: What to Look Out for
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/29 16:33
STAAR Surgical (STAA) to Report Q2 Earnings: What's in Store?
STAAR Surgical's (STAA) ICL line of products is likely to have boosted Q2 performance amid the coronavirus pandemic.
Zacks · 07/29 13:24
Were Hedge Funds Right About STAAR Surgical Company (STAA)?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which
Insider Monkey · 07/28 00:31
Analysts Estimate Staar Surgical (STAA) to Report a Decline in Earnings: What to Look Out for
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/22 16:32
STAAR Surgical to Report Second Quarter Results on August 5, 2020
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the second quarter ended July 3, 2020 on Wednesda
Business Wire · 07/22 11:00

Industry

Medical Equipment, Supplies & Distribution
-0.65%
Healthcare Equipment & Supplies
-0.72%

Hot Stocks

Symbol
Price
%Change

About STAA

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It manufactures lenses used in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. As of December 29, 2017, the Company sold its products in over 75 countries, with distribution in the United States, Canada, Japan and Spain.
More

Webull offers kinds of STAAR Surgical Company stock information, including NASDAQ:STAA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STAA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading STAA stock methods without spending real money on the virtual paper trading platform.